Merck/Schering Receives US Approval

Merck received US anti trust approval of its merger with Schering Plough. They are waiting on Chinese approval, which is a mere formality. The deal will likely close next week. I expect the health care sector to get a boost as it did when the Pfizer/Wyeth deal closed. The boost will likely be smaller as the cash component of this deal is smaller.

No comments: